Table 2: Relationship between demographic and clinical variables and the occurrence of HIV-sensory neuropathy.

VariablesSN present
SN absent
value

Mean age ± SD, years 0.03
Male ( )48 (45.7%)57 (54.3%)0.09
Female ( )78 (35.8%)140 (64.2%)
Mean height ± SD, metres 0.15
HAART treated ( )60 (42.3%)82 (57.7%)0.29
HAART naïve ( )66 (36.5%)115 (63.5%)
Mean duration of HAART ± SD, months* 0.59
Stavudine-based HAART ( )10 (83.3%)2 (16.7%) 0.003**
Non-stavudine-based HAART ( )50 (38.5%)80 (61.5%)
Mean CD4 count ± SD, cells/mm3 0.002
Median CD4 count ± SD, cells/mm3165.5185.0
CD4 count ≤ 200, cells/mm3 ( )74 (42.0%)102 (58.0%) 0.22
CD4 count >200, cells/mm3 ( )52 (35.4%)95 (64.6%)

*Duration of therapy for the 142 participants on HAART therapy. **Fisher’s exact value.